Convergence Investment Partners’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-24,134
Closed -$2.1M 434
2017
Q2
$2.1M Sell
24,134
-44,020
-65% -$3.28M 0.31% 123
2017
Q1
$4.3M Sell
68,154
-1,665
-2% -$110K 0.6% 29
2016
Q4
$4.59M Buy
69,819
+62,808
+896% +$3.94M 0.63% 30
2016
Q3
$487K Buy
+7,011
New +$473K 0.07% 286
2015
Q2
Sell
-57,522
Closed -$3.97M 447
2015
Q1
$3.97M Buy
57,522
+3,552
+7% +$226K 0.55% 41
2014
Q4
$3M Buy
53,970
+9,720
+22% +$561K 0.4% 80
2014
Q3
$2.79M Buy
44,250
+15,509
+54% +$884K 0.38% 85
2014
Q2
$1.52M Buy
+28,741
New +$1.44M 0.2% 169

Other funds holding PRXL

Convergence Investment Partners's PRXL Position: Q3 2017 in Review

Convergence Investment Partners sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 24,134 shares — an estimated $2.1M sold.

Convergence Investment Partners first reported a position in PRXL in Q2 2014 and held it in 8 quarters. The position peaked at $4.59M in Q4 2016. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Convergence Investment Partners reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Convergence Investment Partners sold 24,134 Parexel International Corp shares in Q3 2017, an estimated $2.1M.
  • Convergence Investment Partners first reported a position in Parexel International Corp in Q2 2014 and held it in 8 quarters.
  • Convergence Investment Partners's Parexel International Corp position peaked at $4.59M in Q4 2016.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Convergence Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.